Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity

Scolaris Content Display Scolaris Content Display

Ir a:

Figure 1

Study flow diagram.

Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

$Comparison 1 Unfractionated heparin versus low molecular weight heparin, Outcome 1 Deep vein thrombosis (DVT).$

Analysis 1.1

Comparison 1 Unfractionated heparin versus low molecular weight heparin, Outcome 1 Deep vein thrombosis (DVT).

Analysis 2.1

Comparison 2 Heparin versus placebo, Outcome 1 Pulmonary embolism.

Comparison 1. Unfractionated heparin versus low molecular weight heparin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Deep vein thrombosis (DVT) Show forest plot	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected

Comparison 1. Unfractionated heparin versus low molecular weight heparin

Comparison 2. Heparin versus placebo

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Pulmonary embolism Show forest plot	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected

1.1 Above knee amputation	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 Below knee amputation	1		Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 2. Heparin versus placebo